Tonix Pharmaceuticals Holding TNXP
NASDAQ TNXP
$4.11 -0.38 (-8.35%)
As of: Nov 10, 2026 · 3:58 PM EST

Tonix Pharmaceuticals Holding (TNXP) Convertible Debt (2011)

Updated

Tonix Pharmaceuticals Holding (TNXP) posted Convertible Debt of $2.08 million for Q4 2011.

Analysis

Tonix Pharmaceuticals Holding (TNXP) Convertible Debt (2011) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Tonix Pharmaceuticals Holding 74.61 Mn -684.78 Mn 12.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 2.08 Mn
API Access

Tonix Pharmaceuticals Holding Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=TNXP&period=max&api_key=YOUR_API_KEY